Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, Schwartz S, Steffen B, Spriewald B, Heinicke T, Jäkel N, Westermann J, Nachtkamp K, Viardot A, Topp MS, Neumann M, Baldus CD, Gökbuget N, Brüggemann M.
Burmeister T, et al. Among authors: gokbuget n.
Leukemia. 2024 Mar 22. doi: 10.1038/s41375-024-02209-7. Online ahead of print.
Leukemia. 2024.
PMID: 38519799
No abstract available.